Effect of IL-12 and soluble IL-4 receptor on the herpesvirus infection in human SCID chimeras whose Th2 cells predominate

Immunology and Cell Biology

Volumn 82, Issue 4, 2004, Pages 421-426

  Katakura, Tatsushi ^a   Kobayashi, Makiko ^a,b   Herndon, David N ^b   Suzuki, Fujio ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

Burn injury; Herpesvirus; IL 12; Soluble IL 4 receptor

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 4 RECEPTOR; MONOCLONAL ANTIBODY CD3; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHIMERA; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE MODEL; DONOR; DRUG EFFECT; EXPERIMENT; HERPES SIMPLEX VIRUS 1; HERPES VIRUS INFECTION; HUMAN; HUMAN CELL; IMMUNOREGULATION; INFECTION SENSITIVITY; INJECTION; MALE; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; REGULATORY MECHANISM; SERUM; STIMULATION; SURVIVAL RATE; TH1 CELL; TH2 CELL;

ANIMALS; BURNS; CHIMERA; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HUMANS; INTERFERON-GAMMA, RECOMBINANT; INTERLEUKIN-12; MALE; MICE; MICE, SCID; RECEPTORS, INTERLEUKIN-4; RECOMBINANT PROTEINS; TH2 CELLS;

ANIMALIA; DNA VIRUSES; HERPES; HERPESVIRIDAE; HUMAN HERPESVIRUS 1;

EID: 4344632565     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0818-9641.2004.01266.x     Document Type: Article

References (37)

1. Mandell LA. Infections in the compromised host. J. Int. Med. Res. 1990; 18: 177-90.
2. Wolf SE, Rose JK, Desai MH, Mileski JP, Barrow RE, Herndon DN. Mortality determinants in massive pediatric burns. An analysis of 103 children with >80% TBSA burns (>70% full-thickness). Ann. Surg. 1997; 225: 554-65.
3. Davey V. Immunocompromised persons and emerging infectious diseases. In: Lashley FR, Durham JD, (eds). Emerging Infectious Diseases. New York: Springer Publishing, 2002; 303-24.
4. Linares HA. A report of 115 consecutive autopsies in burned children. Burns 1982; 8: 263-70.
5. Seeman J, Konigova R. Cytomegalovirus infection in severely burned patients. Acta. Chir. Plast. 1976; 18: 142-51.
6. Seeman J, Konigova R, Lysenkova I. Fatal outcome of cytomegalovirus infections in severe burns. Acta. Chir. Plast. 1980; 22: 166-70.
7. Kagan RJ, Naraqi S, Matsuda T, Jonasson OM. Herpes simplex virus and cytomegalovirus infections in burned patients. J. Trauma 1985; 25: 40-5.
8. Pensler JM, Herndon DN, Ptak H et al. Fungal sepsis: An increasing problem in major thermal injuries. J. Burn Care Rehab. 1986; 7: 488-91.
9. Odds FC. Ecology and epidemiology of Candida. In: Candida and Candidosis. Baltimore: University Park Press 1979; 50-74.
10. Rubin RH. Fungal and bacterial infections in the immunocompromised host. Eur. J. Clin. Microbiol. Infect. Dis. 1993; 12: S42-8.
11. Munster AM. Post-traumatic immunosuppression is due to activation of suppressor T cells. Lanset 1976; 1: 1329-30.
12. Markley K, Smallman ET. Effect of thermal trauma on numbers and function of T and B cells from mouse spleen. Int. Arch Allergy Appl. Immunol. 1977; 54: 238-46.
13. Miller CL, Baker CC. Changes in lymphocyte activity after thermal injury. J. Clin. Invest. 1979; 63: 202-10.
14. McIrvine AJ, O'Mahony JB, Saporoschetz I, Mannick JA. Depressed immune response in burn patients. Use of monoclonal antibodies and functional assays to define the role of suppressor cells. Ann. Surg. 1982; 196: 297-304.
15. Stein MD, Gamble DN, Klimpel KD, Herndon DN, Klimpel GR. Natural killer cell defects resulting from thermal injury. Cell. Immunol. 1984; 86: 551-6.
16. Ninnemann JL. Trauma, sepsis, and the immune response. J. Burn Care Rehab. 1987; 8: 462-8.
17. Faist E, Kupper TS, Baker CC, Chaudry IH, Dwyer J, Baue AE. Depression of cellular immunity after major injury: Its association with posttraumatic complications and its reversal with immunomodulation. Arch. Surg. 1986; 121: 1000-5.
18. Mistry S, Mistry NP, Arora S, Antia NH. Cellular immune response following thermal injury in human patients. Burns 1986; 12: 318-24.
19. Hansbrough JF, Zapata-Sirvent RL, Peterson VM. Immunomodulation following burn injury. Surg. Clin. N. Am. 1987; 67: 69-92.
20. Smith A, Barclay C, Quaba A et al. The bigger the burn, the greater the stress. Burns 1997; 23: 291-4.
21. O'Sullivan ST, Lederer JA, Horgan AF, Chin DH, Mannick JA, Rodrick ML. Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann. Surg. 1995; 222: 482-92.
22. Decker D, Schondorf M, Bidlingmaier F, Hirner A, von Ruecker AA. Surgical stress induces a shift in the type-1/type-2 T-helper cell balance, suggesting down-regulation of cell-mediated and up-regulation of antibody-mediated immunity commensurate to the trauma. Surgery 1996; 119: 316-25.
23. Kobayashi M, Mori K, Kobayashi H, Pollard RB, Suzuki F. The regulation of burn-associated infections with herpes simplex virus type 1 or Candida albicans by a non-toxic aconitine-hydrolysate, benzoylmesaconine. Part 1: Antiviral and antifungal activities in thermally injured mice. Immunol. Cell Biol. 1998; 76: 202-8.
24. Kobayashi M, Kobayashi H, Mori K, Pollard RB, Suzuki F. The regulation of burn-associated infections with herpes simplex virus type 1 or Candida albicans by a non-toxic aconitine-hydrolysate, benzoylmesaconine. Part 2: Mechanism of the antiviral action. Immunol. Cell Biol. 1998; 76: 209-16.
25. Kobayashi H, Kobayashi M, Utsunomiya T, Herndon DN, Pollard RB, Suzuki F. Therapeutic protective effects of IL-12 combined with soluble IL-4 receptor against established infections of herpes simplex virus type 1 in thermally injured mice. J. Immunol. 1999; 162: 7148-54.
26. Katakura T, Kobayashi M, Fujita K, Herndon DN, Pollard RB, Suzuki F. A combination therapy using IL-12 and soluble IL-4 receptor on herpes simplex virus type 1 infection in a human-SCID chimera model of thermal injury. Clin. Immunol. 2002; 105: 363-70.
27. + type 2 T cells. J. Leukoc. Biol. 1998; 63: 723-31.
28. Simpson E, Farrant J, Chandler P. Phenotypic and functional studies of human peripheral blood lymphocytes engrafted in SCID mice. Immunol. Rev. 1991; 124: 97-111.
29. Tary-Lehmann M, Saxon A, Lehmann PV. The human immune system in hu-PBL-SCID mice. Immunol. Today 1995; 16: 529-33.
30. Del Prete GD, Romagnani S. The role of Th1 and Th2 subsets in human infectious diseases. Trends Microbiol. 1994; 2: 4-6.
31. Romagnani S. Understanding the role of Th1/Th2 cells in infection. Trends Microbiol. 1996; 4: 470-3.
32. Fitch FW, Mckisic MD, Lancki DW, Gajewski TF. Differential regulation of murine T lymphocyte subsets. Annu. Rev. Immunol. 1993; 11: 29-48.
33. Tracey KJ, Fong Y, Hesse DG et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 1987; 330: 662-4.
34. Natanson C, Hoffman WD, Suffredini AF, Eichacker PQ, Danner RL. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann. Inter. Med. 1994; 120: 771-83.
35. Akira S. Functional roles of STAT family proteins: Lessons from knockout mice. Stem Cells 1999; 17: 138-46.
36. Thierfelder WE, van Deursen JM, Yamamoto K, et al. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 1996; 382: 171-4.
37. Kaplan MH, Schindler U, Smiley ST, Grusby MJ. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 1996; 4: 313-9.